Good Clinical Practice for Drugs
On April 23, 2020, the State Food and Drug Administration and the National Health Commission issued an announcement on the release of quality management practices for drug clinical trials (No. 57, 2020). This announcement is to deepen the reform of the drug review and approval system, encourage innovation, and further promote the standardized research and quality improvement of drug clinical trials in my country. The State Food and Drug Administration, together with the National Health Commission, organized the revision of the "Good Clinical Practice Practice for Drugs". Since 2020 It will come into effect on July 1, 2019.
